{"id":171,"date":"2016-03-11T11:17:53","date_gmt":"2016-03-11T16:17:53","guid":{"rendered":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/?page_id=171"},"modified":"2016-03-11T11:17:53","modified_gmt":"2016-03-11T16:17:53","slug":"2014-guest-speaker","status":"publish","type":"page","link":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/2014-guest-speaker\/","title":{"rendered":"2014 Guest Speaker"},"content":{"rendered":"<h3 style=\"text-align: center\">David Ransohoff, MD<br \/>\n2014 Guest Speaker<\/h3>\n<p>David Ransohoff is an internist (gastroenterology, University of  Chicago) and clinical epidemiologist (Yale) with longstanding interest  in improving the methods used to evaluate diagnostic tests, particularly  for screening. In 1978, he and clinical epidemiology mentor Alvan  Feinstein wrote a NEJM paper that helped establish the field of methods  to evaluate diagnostic tests.\u00a0After studying conventional tests for  cancer and other diseases, 15 years ago he extended his work to include  molecular tests after being introduced to this area by EXACT Sciences  (stool-based DNA markers for colon cancer; NEJM, 2004, 2014) and by a  sabbatical with NCI. \u00a0He has also studied\u00a0\u00a0 blood-based  markers (DNA, proteomics) for colon and ovarian cancer screening. At the  University of North Carolina at Chapel Hill, Dr. Ransohoff has directed  faculty development programs including the Robert Wood Johnson Clinical  Scholars Program and the NIH-supported K30 program in translational  research, now in the CTSA. He was also the inaugural speaker for NIH\u2019s  \u201cMind the Gap\u201d seminar series.\u00a0He currently works closely with  staff and investigators at NCI on topics related to molecular markers  for cancer screening.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>David Ransohoff, MD 2014 Guest Speaker David Ransohoff is an internist (gastroenterology, University of Chicago) and clinical epidemiologist (Yale) with longstanding interest in improving the methods used to evaluate diagnostic tests, particularly for screening. In 1978, he and clinical epidemiology mentor Alvan Feinstein wrote a NEJM paper that helped establish the field of methods to&#8230;<\/p>\n","protected":false},"author":2430,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"tags":[],"class_list":["post-171","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/pages\/171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/users\/2430"}],"replies":[{"embeddable":true,"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/comments?post=171"}],"version-history":[{"count":1,"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/pages\/171\/revisions"}],"predecessor-version":[{"id":173,"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/pages\/171\/revisions\/173"}],"wp:attachment":[{"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/media?parent=171"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/my.dev.vanderbilt.edu\/translationalresearchforum\/wp-json\/wp\/v2\/tags?post=171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}